Immersion Medical and Laerdal Medical A/S Collaborate to Promote Intravenous Access Training.

SAN JOSE, Calif. -- Immersion Medical, a subsidiary of Immersion Corporation, a leading developer and licensor of touch feedback technology (Nasdaq:IMMR), and Laerdal Medical A/S, a leading developer of educational products for the evolving needs of emergency medicine, have started producing and selling an intravenous simulator, the Virtual IV system. Laerdal is marketing and selling the Virtual IV system worldwide. Immersion Medical is developing and manufacturing the system and selling it in the U.S. The companies have a combined sales force of over 500 people operating in 22 countries.

A realistic, state-of-the-art, computer-based simulator, the Virtual IV system promotes the development, maintenance, and assessment of the motor skills and cognitive knowledge needed to perform intravenous access procedures. It allows students, nurses, and other practitioners to practice intravenous skills to help obtain and maintain proficiency and nurse educators and program directors to fulfill training needs.

Dedicated training in intravenous access procedures can improve the quality of health care. Over 80% of hospital patients receive IV therapy during their hospital stays and inappropriate insertion can produce complications, increase patient discomfort, and impact treatment.(1) In addition, an estimated 600,000 needle-stick injuries occur in U.S. health care settings annually, and a large percentage of these carry the threat of blood-borne diseases.(2)

The National League for Nursing finds the use of simulation is growing. In its report on educational trends, simulation is among the top 5 of 42 teaching items that received more emphasis in 2003 than in 1998 and is "expected to have greater emphasis in 2008."(3) Moreover, a Frost & Sullivan return-on-investment study for intravenous access simulators showed a median payback period of less than three months based on procedural and instructor time savings, reduction in errors, and other factors.

"This is a wonderful opportunity for nursing education programs and trainers," said Richard Vogel, general manager of Immersion Medical. "Two quality-focused, reputable, and trusted organizations have come together to offer a comprehensive array of training tools and resources to the nursing community. This relationship provides an expanded opportunity for those interested in providing high quality, affordable IV training."

(1) Rosenthal, K. Get a hold on costs and safety with securement
    devices. Nursing Management. May 2005:52-53.

(2) U.S. Department of Labor, www.osha.gov, Occupational Exposure to
    Bloodborne Pathogens; Needlestick and Other Sharps Injuries;
    Supplementary Information to the Final Rule.

(3) Trends in Registered Nurse Education Programs 1998-2008: Summary
    Report; Streubert Speziale, Helen J. EdD, RN; Jacobson, Linbania
    (Lin) EdD, RN, CPHQ.

About Laerdal Medical (www.laerdal.com)

Laerdal is an educational company specializing in products that meet the evolving needs of emergency medicine. The company is dedicated to providing educational efficiency, economic value, and clinical accuracy. Its product lines include manikins, skills trainers, patient simulators, computer skill simulators, micro simulators, and knowledge resources.

About Immersion Medical, Inc. (www.immersionmedical.com)

Immersion Medical, Inc., a division of Immersion Corporation and a leader in medical and surgical simulation, develops, manufactures and markets computer-based medical training simulation systems worldwide. Immersion Medical integrates proprietary software, hardware, and patented tactile feedback technology to simulate highly realistic medical procedures that help train clinicians. The company's four key product lines are the Endovascular AccuTouch(R) System, Endoscopy AccuTouch System, Laparoscopy AccuTouch System, and Virtual IV system.

About Immersion (www.immersion.com)

Founded in 1993, Immersion Corporation is a recognized leader in developing, licensing, and marketing digital touch technology and products. Using Immersion's advanced touch feedback technology, electronic user interfaces can be made more productive, compelling, entertaining, or safer. Immersion's technology is deployed across automotive, entertainment, industrial controls, medical training, mobility, and three-dimensional simulation markets. Immersion's patent portfolio includes over 600 issued or pending patents in the U.S. and other countries.

Forward-Looking Statements

This press release contains "forward-looking statements" that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause the results of Immersion Corporation and its consolidated subsidiaries to differ materially from those expressed or implied by such forward-looking statements.

All statements, other than the statements of historical fact, are statements that may be deemed forward-looking statements, including any projections of earnings, revenues, or other financial matters; any statements of the plans, strategies, and objectives of management for future operations; any statements concerning consumer response that may occur as a result of the new simulator release, or consumer or market acceptance of simulator products for medical training, continuing education or evaluation or consumer and market acceptance of force feedback products in general; proposed products or services; any statements regarding future economic conditions or performance; statements of belief; and any statement or assumptions underlying any of the foregoing. Immersion's actual results might differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with Immersion's business which include, but are not limited to, delay in or failure to achieve commercial demand for Immersion's products or a delay in or failure to achieve the acceptance of force feedback as a critical user experience.

For a more detailed discussion of these factors, and other factors that could cause Immersion's actual results to vary materially, interested parties should review the risk factors listed in Immersion's most current Form 10-Q, which are on file with the U.S. Securities and Exchange Commission. The forward-looking statements in this press release reflect Immersion's beliefs and predictions as of the date of this release. Immersion disclaims any obligation to update these forward-looking statements as a result of financial, business, or any other developments occurring after the date of this release.

Immersion, the Immersion logo, and AccuTouch are trademarks of Immersion Corporation in the United States and other countries. All other trademarks are the property of their respective owners.